Resource Roundup: Integrative Interventions for Depression and Anxiety

Avery St. Onge

November 12, 2024
PeopleImages.com - Yuri A/Shutterstock

Exploring the Future of Psychedelic Therapy in Clinical Practice

Emily Whinkin, ND, joins Integrative Practitioner Content Specialist Avery St. Onge to discuss how the Federal Drug Administration’s (FDA) rejection of MDMA-assisted therapy for PTSD impacts the future of psychedelic therapy in the United States.

Emily Whinkin, ND (she/they), is an integrative mental health practitioner, researcher, and psychonaut currently practicing at the Advanced Integrative Medical Science Institute in Seattle.

To listen now, click here.

About the Author:

Avery St. Onge

Avery St. Onge is the Content Specialist of Integrative Practitioner and Natural Medicine Journal. In addition to producing written content, Avery hosts the Integrative Practitioner Podcast and organizes Integrative Practitioner's webinars and digital summits. She graduated from George Washington University in 2021, where she studied journalism and mass communications. As a person with type 1 diabetes, Avery is hyperaware of the benefits of a holistic, mind/body approach to healthcare and is committed to sharing the latest news in integrative medicine.

© 2024 Diversified Communications. All rights reserved.
Diversified Communications